Japan Cough Syrup Market Forecast 2023-2030
KEY FINDINGS
The Japan cough syrup market is set to grow at a CAGR of 4.19% during the forecast period, 2023-2030. The market growth is driven by the increasing air pollution, changing lifestyles, and a growing awareness of healthcare. In addition, cough syrup manufacturers in Japan are focusing on research and development to introduce innovative formulations and expand their product portfolios.
REGIONAL INSIGHTS
Japan has a robust national healthcare policy that underscores the importance of making healthcare items, such as medications, economical and easily obtainable for all its citizens. The government actively oversees drug prices, promotes the utilization of generic medicines, and engages in negotiations with pharmaceutical companies to manage healthcare expenses. This strategy ensures that cough syrups and other vital medications remain accessible to both the elderly and the general population.
Furthermore, the presence of reasonably priced and readily accessible healthcare products aligns with Japan's healthcare system, which places a strong emphasis on preventive measures and early intervention. Japanese citizens are encouraged to promptly seek medical attention and treatment for common ailments, which includes the utilization of over-the-counter cough syrups for addressing mild respiratory symptoms. Moreover, the Ministry of Health, Labour and Welfare (MHLW) oversees pharmaceutical products in Japan. It enforces stringent regulations to ensure the quality, safety, and efficacy of cough syrup products, assuring consumers of their reliability.
COMPETITIVE INSIGHTS
Some of the eminent companies in the market include GSK plc, Procter & Gamble, Reckitt Benckiser Group PLC, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
- 1. Research Scope & Methodology
- 1.1. Study Objectives
- 1.2. Methodology
- 1.3. Assumptions & Limitations
- 2. Executive Summary
- 2.1. Market Size & Estimates
- 2.2. Country Snapshot
- 2.3. Country Analysis
- 2.4. Scope Of Study
- 2.5. Crisis Scenario Analysis
- 2.5.1. Impact Of Covid-19 On Cough Syrup Market
- 2.5.2. Impact Of The Russia-ukraine War On Cough Syrup Market
- 2.6. Major Market Findings
- 2.6.1. Product Diversification Is On The Rise
- 2.6.2. Dominance Of Otc Cough Syrups Has Driven Accessibility
- 2.6.3. Healthcare Information Availability On Digital Platforms Influences Consumer Choices
- 3. Market Dynamics
- 3.1. Key Drivers
- 3.1.1. Prevalence Of Respiratory Ailments
- 3.1.2. Rising Geriatric Population
- 3.1.3. Innovations In Cough Syrups
- 3.2. Key Restraints
- 3.2.1. Over-dosage Concerns Driving Consumers Toward Alternatives
- 3.2.2. Stringent Regulatory Protocols
- 3.2.3. Increasing Cases Of Cough Syrup Deaths
- 4. Key Analytics
- 4.1. Key Market Trends
- 4.1.1. Increasing Self-medication Trends
- 4.1.2. Shifting Consumer Preference Toward Herbal Cough Syrups
- 4.1.3. Rising Popularity Of E-commerce Channels
- 4.1.4. Companies Are Offering Sugar-free Cough Syrups
- 4.1.5. Growing Inclination Toward Homeopathic Cough Syrups
- 4.2. Pest Analysis
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Buyers Power
- 4.3.2. Suppliers Power
- 4.3.3. Substitution
- 4.3.4. New Entrants
- 4.3.5. Industry Rivalry
- 4.4. Growth Prospect Mapping
- 4.4.1. Growth Prospect Mapping For Japan
- 4.5. Value Chain Analysis
- 5. Market By Product Type
- 5.1. Cough Suppressants
- 5.1.1. Market Forecast Figure
- 5.1.2. Segment Analysis
- 5.2. Combination Medicines
- 5.2.1. Market Forecast Figure
- 5.2.2. Segment Analysis
- 5.3. Expectorants
- 5.3.1. Market Forecast Figure
- 5.3.2. Segment Analysis
- 6. Market By Age Group
- 6.1. Adults
- 6.1.1. Market Forecast Figure
- 6.1.2. Segment Analysis
- 6.2. Adolescents
- 6.2.1. Market Forecast Figure
- 6.2.2. Segment Analysis
- 6.3. Pediatric
- 6.3.1. Market Forecast Figure
- 6.3.2. Segment Analysis
- 7. Market By Distribution Channel
- 7.1. Retail Pharmacies
- 7.1.1. Market Forecast Figure
- 7.1.2. Segment Analysis
- 7.2. Hospital Pharmacies
- 7.2.1. Market Forecast Figure
- 7.2.2. Segment Analysis
- 7.3. E-pharmacies
- 7.3.1. Market Forecast Figure
- 7.3.2. Segment Analysis
- 8. Competitive Landscape
- 8.1. Key Strategic Developments
- 8.1.1. Mergers & Acquisitions
- 8.1.2. Product Launches & Developments
- 8.1.3. Partnerships & Agreements
- 8.1.4. Business Expansions & Divestitures
- 8.2. Company Profiles
- 8.2.1. Gsk Plc
- 8.2.1.1. Company Overview
- 8.2.1.2. Product List
- 8.2.1.3. Strengths & Challenges
- 8.2.2. Novartis Ag
- 8.2.2.1. Company Overview
- 8.2.2.2. Product List
- 8.2.2.3. Strengths & Challenges
- 8.2.3. Pfizer Inc
- 8.2.3.1. Company Overview
- 8.2.3.2. Product List
- 8.2.3.3. Strengths & Challenges
- 8.2.4. Procter & Gamble
- 8.2.4.1. Company Overview
- 8.2.4.2. Product List
- 8.2.4.3. Strengths & Challenges
- 8.2.5. Reckitt Benckiser Group Plc
- 8.2.5.1. Company Overview
- 8.2.5.2. Product List
- 8.2.5.3. Strengths & Challenges
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook